These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 37300959)
1. Novel flavonoid 1,3,4-oxadiazole derivatives ameliorate MPTP-induced Parkinson's disease via Nrf2/NF-κB signaling pathway. Meng HW; Shen ZB; Meng XS; Leng-Wei ; Yin ZQ; Wang XR; Zou TF; Liu ZG; Wang TX; Zhang S; Chen YL; Yang XX; Li QS; Duan YJ Bioorg Chem; 2023 Sep; 138():106654. PubMed ID: 37300959 [TBL] [Abstract][Full Text] [Related]
2. Sofalcone attenuates neurodegeneration in MPTP-induced mouse model of Parkinson's disease by inhibiting oxidative stress and neuroinflammation. Chen M; He X; Fan Y; Xia L; Dong Z Mol Biol Rep; 2024 Aug; 51(1):908. PubMed ID: 39141244 [TBL] [Abstract][Full Text] [Related]
3. Distinct Nrf2 Signaling Mechanisms of Fumaric Acid Esters and Their Role in Neuroprotection against 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Induced Experimental Parkinson's-Like Disease. Ahuja M; Ammal Kaidery N; Yang L; Calingasan N; Smirnova N; Gaisin A; Gaisina IN; Gazaryan I; Hushpulian DM; Kaddour-Djebbar I; Bollag WB; Morgan JC; Ratan RR; Starkov AA; Beal MF; Thomas B J Neurosci; 2016 Jun; 36(23):6332-51. PubMed ID: 27277809 [TBL] [Abstract][Full Text] [Related]
4. Design, synthesis, and SAR study of novel flavone 1,2,4-oxadiazole derivatives with anti-inflammatory activities for the treatment of Parkinson's disease. Shen ZB; Meng HW; Meng XS; Lv ZK; Fang MY; Zhang LL; Lv ZL; Li MS; Liu AK; Han JH; Li QS; Duan YJ Eur J Med Chem; 2023 Jul; 255():115417. PubMed ID: 37137246 [TBL] [Abstract][Full Text] [Related]
5. Bruceine D elevates Nrf2 activation to restrain Parkinson's disease in mice through suppressing oxidative stress and inflammatory response. Yang Y; Kong F; Ding Q; Cai Y; Hao Y; Tang B Biochem Biophys Res Commun; 2020 Jun; 526(4):1013-1020. PubMed ID: 32321640 [TBL] [Abstract][Full Text] [Related]
6. A novel compound VSC2 has anti-inflammatory and antioxidant properties in microglia and in Parkinson's disease animal model. Lee JA; Kim JH; Woo SY; Son HJ; Han SH; Jang BK; Choi JW; Kim DJ; Park KD; Hwang O Br J Pharmacol; 2015 Feb; 172(4):1087-100. PubMed ID: 25297649 [TBL] [Abstract][Full Text] [Related]
7. Calycosin attenuates MPTP-induced Parkinson's disease by suppressing the activation of TLR/NF-κB and MAPK pathways. Yang J; Jia M; Zhang X; Wang P Phytother Res; 2019 Feb; 33(2):309-318. PubMed ID: 30421460 [TBL] [Abstract][Full Text] [Related]
8. 5-(3,4-Difluorophenyl)-3-(6-methylpyridin-3-yl)-1,2,4-oxadiazole (DDO-7263), a novel Nrf2 activator targeting brain tissue, protects against MPTP-induced subacute Parkinson's disease in mice by inhibiting the NLRP3 inflammasome and protects PC12 cells against oxidative stress. Xu LL; Wu YF; Yan F; Li CC; Dai Z; You QD; Jiang ZY; Di B Free Radic Biol Med; 2019 Apr; 134():288-303. PubMed ID: 30615919 [TBL] [Abstract][Full Text] [Related]
9. Ginsenoside Rk1 prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson's disease via activating silence information regulator 3-mediated Nrf2/HO-1 signaling pathway. Ren Y; Ye D; Ding Y; Wei N Hum Exp Toxicol; 2023; 42():9603271231220610. PubMed ID: 38105596 [No Abstract] [Full Text] [Related]
10. The Neuroprotective Effect of Dimethyl Fumarate in an MPTP-Mouse Model of Parkinson's Disease: Involvement of Reactive Oxygen Species/Nuclear Factor-κB/Nuclear Transcription Factor Related to NF-E2. Campolo M; Casili G; Biundo F; Crupi R; Cordaro M; Cuzzocrea S; Esposito E Antioxid Redox Signal; 2017 Sep; 27(8):453-471. PubMed ID: 28006954 [TBL] [Abstract][Full Text] [Related]
11. Neuroprotective and Anti-Inflammatory Effects of Evernic Acid in an MPTP-Induced Parkinson's Disease Model. Lee S; Suh YJ; Yang S; Hong DG; Ishigami A; Kim H; Hur JS; Chang SC; Lee J Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33672606 [TBL] [Abstract][Full Text] [Related]
12. The TLR4/NF-κB/NLRP3 and Nrf2/HO-1 pathways mediate the neuroprotective effects of alkaloids extracted from Uncaria rhynchophylla in Parkinson's disease. Zhang C; Zhou J; Zhuo L; Zhang W; Lv L; Zhu L; Zhang J; Feng F; Liu W; Han L; Liao W J Ethnopharmacol; 2024 Oct; 333():118391. PubMed ID: 38797377 [TBL] [Abstract][Full Text] [Related]
13. Phytic acid attenuates inflammatory responses and the levels of NF-κB and p-ERK in MPTP-induced Parkinson's disease model of mice. Lv Y; Zhang Z; Hou L; Zhang L; Zhang J; Wang Y; Liu C; Xu P; Liu L; Gai X; Lu T Neurosci Lett; 2015 Jun; 597():132-6. PubMed ID: 25929185 [TBL] [Abstract][Full Text] [Related]
14. Anti-Inflammatory and Neuroprotective Mechanisms of GTS-21, an α7 Nicotinic Acetylcholine Receptor Agonist, in Neuroinflammation and Parkinson's Disease Mouse Models. Park JE; Leem YH; Park JS; Kim DY; Kang JL; Kim HS Int J Mol Sci; 2022 Apr; 23(8):. PubMed ID: 35457238 [TBL] [Abstract][Full Text] [Related]
15. Isobavachalcone Attenuates MPTP-Induced Parkinson's Disease in Mice by Inhibition of Microglial Activation through NF-κB Pathway. Jing H; Wang S; Wang M; Fu W; Zhang C; Xu D PLoS One; 2017; 12(1):e0169560. PubMed ID: 28060896 [TBL] [Abstract][Full Text] [Related]
16. Baicalin exerts neuroprotective actions by regulating the Nrf2-NLRP3 axis in toxin-induced models of Parkinson's disease. Huang J; Zhang X; Yang X; Yv Q; Ye F; Chen S; Cui Y; Gu L; Zhu M; Li W Chem Biol Interact; 2024 Jan; 387():110820. PubMed ID: 38016618 [TBL] [Abstract][Full Text] [Related]
17. Wuzi Yanzong Pill relieves MPTP-induced motor dysfunction and neuron loss by inhibiting NLRP3 inflammasome-mediated neuroinflammation. Pan T; Xiao Q; Fan HJ; Xu L; Qin SC; Yang LX; Jin XM; Xiao BG; Zhang B; Ma CG; Chai Z Metab Brain Dis; 2023 Oct; 38(7):2211-2222. PubMed ID: 37470879 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of the TLR/NF- Su Y; Li M; Wang Q; Xu X; Qin P; Huang H; Zhang Y; Zhou Y; Yan J Oxid Med Cell Longev; 2022; 2022():1837278. PubMed ID: 36589679 [TBL] [Abstract][Full Text] [Related]
19. Vitamin E Analog Trolox Attenuates MPTP-Induced Parkinson's Disease in Mice, Mitigating Oxidative Stress, Neuroinflammation, and Motor Impairment. Atiq A; Lee HJ; Khan A; Kang MH; Rehman IU; Ahmad R; Tahir M; Ali J; Choe K; Park JS; Kim MO Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373089 [TBL] [Abstract][Full Text] [Related]
20. Astragaloside IV ameliorates motor deficits and dopaminergic neuron degeneration via inhibiting neuroinflammation and oxidative stress in a Parkinson's disease mouse model. Yang C; Mo Y; Xu E; Wen H; Wei R; Li S; Zheng J; Li W; Le B; Chen Y; Pan H; Huang S; Wang S; Wang Q Int Immunopharmacol; 2019 Oct; 75():105651. PubMed ID: 31401385 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]